SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VIDAMED-"FDA Approval Imminent" (VIDA)
VIDA 0.000010000.0%Oct 31 9:30 AM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: noronha who wrote (17)1/31/1997 5:35:00 PM
From: dper   of 53
 
Just recently became aware of this company and the product and it looks promising to say the least. They signed a potentially lucrative contract with Tenet Healthcare in California to train urologists in the procedure. Also note that they have designed a poison pill to avoid takeover prospects, although the news summary of the details was confusing to non-financial types like me.

Just one note of concern: it seems to be vulnerable in that it is a one trick pony. Do they have any other product besides this TUNA system? I potentially worry that if somebody has a side effect that was unforseen or if a urological journal article exposes a fatal flaw to the technique (or is even mildly unenthusiastic) then the stock is susceptible to wild downward price pressure.

Any information about other products, either currrently available or in the pipeline?

David
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext